Top compounds associated with response to MAMDC4


Feature Type Standardized
Nominal ANOVA
mRNA CR-1-31B CTRPv2 pan-cancer AAC 0.11 0.0008
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA SCH-529074 CTRPv2 pan-cancer AAC 0.13 0.001
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.13 0.001
mRNA parbendazole CTRPv2 pan-cancer AAC 0.096 0.002
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC 0.1 0.003
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
Download CSV